OVERVIEW
The market for HIV diagnosis is projected to reach USD 8.33 billion by 2026, with a CAGR of 8.1 percent from 2021 to 2026. Market growth is expected to be driven by factors such as the increasing global prevalence of HIV/AIDS, the rising number of blood transfusions and blood donations, the benefits offered by point-of-care devices and kits, and increased policy measures. The impact of the COVID-19 outbreak on the industry will be thoroughly evaluated in the following report. The study also contrasts the pre-COVID-19 and post-COVID-19 markets.
TABLE OF CONTENT
- 1 Global HIV Diagnosis Market
- 1.1 Study Objectives
- 1.2 Market Definition
- 1.3 Study Scope
- 1.3.1 Markets Covered
- 1.3.2 Geographic Scope
- 2 RESEARCH METHODOLOGY
- 2.1 Research Data
- 2.1.1 Secondary Data
- 2.1.1.1 Key Data From Secondary Sources
- 2.1.2 Primary Data
- 2.1.2.1 Key Data From Primary Sources
- 2.1.2.2 Key Industry Insights
- 2.1.2.3 Breakdown of Primaries
- 2.1.1 Secondary Data
- 2.2 Market Size Estimation
- 2.2.1 Bottom-Up Approach
- 2.2.2 Top-Down Approach
- 2.3 Market Breakdown and Data Triangulation
- 2.4 Research Assumptions
- 2.1 Research Data
- 3 Global HIV Diagnosis Market ? Executive Summary
- 3.1 Market Revenue, Market Size and Key Trends by Company
- 3.2 Key Trends by type of Application
- 3.3 Key Trends segmented by Geography
- 4 Global HIV Diagnosis Market ? Comparative Analysis
- 4.1 Product Benchmarking - Top 10 companies
- 4.2 Top 5 Financials Analysis
- 4.3 Market Value split by Top 10 companies
- 4.4 Patent Analysis - Top 10 companies
- 4.5 Pricing Analysis
- 5 Global HIV Diagnosis Market ? Industry Market Entry Scenario
- 5.1 Regulatory Framework Overview
- 5.2 New Business and Ease of Doing business index
- 5.3 Case studies of successful ventures
- 5.4 Customer Analysis ? Top 10 companies
- 6 Global HIV Diagnosis Market - Market Forces
- 6.1 Introduction
- 6.2 Market Dynamics
- 6.2.1 Drivers
- 6.2.2 Opportunities
- 6.2.3 Challenges
- 6.3 Porters Analysis of Market
- 6.3.1 Bargaining power of suppliers
- 6.3.2 Bargaining powers of customers
- 6.3.3 Threat of new entrants
- 6.3.4 Rivalry among existing players
- 6.3.5 Threat of substitutes
- 7 Global HIV Diagnosis Market - Strategic Analysis
- 7.1 Value Chain analysis
- 7.2 Supplier and distributor analysis (Market share and product dealing strategies)
- 8 Global HIV Diagnosis Market ? By Product (Market Size ? & million/billion)
- 8.1 Consumables
- 8.2 Instruments
- 8.3 Software & Services
- 9 Global HIV Diagnosis Market - By Test Type
- 9.1 Antibody Tests
- 9.2 Viral Load Tests
- 9.3 CD4 Tests
- 9.4 Tests for Early Infant Diagnosis
- 9.5 Tests for Viral Identification
- 10 Global HIV Diagnosis Market - By End-User
- 10.1 Diagnostic Laboratories
- 10.2 Hospitals
- 10.3 Blood Banks
- 10.4 Home Care Settings
- 10.5 Other
- 11 Global HIV Diagnosis Market ? By Geography (Market Size ? & million/billion)
- 11.1 Introduction
- 11.2 North America
- 11.2.1 US
- 11.2.2 Canada
- 11.2.3 Mexico
- 11.3 Europe
- 11.3.1 U.K
- 11.3.2 Germany
- 11.3.3 Italy
- 11.3.4 France
- 11.3.5 Spain
- 11.3.6 Rest of Europe
- 11.4 Asia-Pacific
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Rest of APAC
- 11.5 Rest of the World
- 11.5.1 South America
- 11.5.2 Middle East
- 11.5.3 Africa
- 12 Global HIV Diagnosis Market ? Entropy
- 12.1 New product launches
- 12.2 M&A's, collaborations, JVs and partnerships
- 13 Global HIV Diagnosis Market Company Profile (Key Players)
- 13.1 Market Share, Company Revenue, Products, M&A, Developments
- 13.2 Siemens Healthineers (A Division of Siemens AG)
- 13.3 Roche Diagnostics (Division of Hoffman La Roche Ltd.)
- 13.4 Merck KGaA
- 13.5 Becton, Dickinson & Company
- 13.6 Abbott Laboratories
- 13.7 Bio-Rad Laboratories
- 13.8 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
- 13.9 Thermo-Fisher Scientific Inc.
- 13.10 Hologic Inc.
- 13.11 Alere Inc.
- 13.12 Company 11 & more
- 14 Global HIV Diagnosis Market - Appendix
- 14.1 Sources
- 14.2 Abbreviations
HIV Diagnosis Market by Product (Instrument, Assay, Kit, Reagent, Software, Services), Test Type (Early Infant, Viral Identification, Antibody, Viral Load, CD4 Count), End User (Hospitals) ? 2022 to 2027
Category: HealthcareSKU: GMS-3163
×